Skip to main content
Premium Trial:

Request an Annual Quote

Richard Groves Goes to Turbo-Worx; Celera Appoints Steven Ruben VP of Protein Therapeutics; Pharmacia VP Named CEO of Celltech

NEW YORK, April 23 - Richard Groves has been named business development director for the new European office of life sciences grid computing provider TurboWorx, the New Haven, Conn., company said April 21.


Groves, who will be based in Oxford, UK, was previously business development director, Europe, for Argentys, formerly Blackstone Computing. He also was scientific service manager , and previously field scientist, of Genomica.  He has has held postdoctoral research fellowships  at the Ludwig Institute for Cancer Research as well as Oxford's department of Pharmacology.


Steven Ruben has been appointed vice president of protein therapeutics for Celera Genomics, the company said April 17.


Ruben, who will oversee the company's target validation efforts as well as protein chemistry, cell biology, and mass spectrometry research, comes to Celera from Rockville, Md., neighbor Human Genome Sciences. He was most recently vice president of research at HGS, where he worked for ten years.



Goran Ando has been named new CEO of UK biotech giant Celltech, which just acquired Oxford Glycosciences in a cash tender offer, the company said April 16.


Ando comes to Celltech from Pharmacia, where he was president of R&D until the company was acquired by Pfizer April 15. Ando has also served as director of R&D for Glaxo Group Research


Ando replaces Peter Fellner, the CEO of Celltech since 1990. Fellner will now serve as chairman of Celltech.




The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.